Drug Profile
Research programme: lipoxin A4 analogues - Bayer HealthCare Pharmaceuticals
Alternative Names: Lipoxin A4 analog - Bayer HealthCare Pharmaceuticals; ZK-192Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Class Antiasthmatics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Crohn's disease